Biden Targets Key Drugs for Medicare Price Reductions
The Biden administration has chosen 10 drugs, including blood thinners, diabetes treatments, and drugs for kidney disease and arthritis, for the first round of price negotiations between Medicare and pharmaceutical companies. The negotiations aim to reduce costs for seniors who rely on these medications, potentially benefiting up to 9 million seniors. However, the pharmaceutical industry has opposed the negotiations, with several major drugmakers suing the Biden administration over the cost-reduction program, claiming it violates the US constitution. Despite the legal challenges, the administration remains committed to lowering drug prices and plans to expand Medicare negotiations for 60 drugs over the next four years.
- Biden names 10 drugs for first negotiations to cut Medicare prices The Guardian US
- Widely used diabetes, heart disease, autoimmune drugs for Medicare price negotiation USA TODAY
- 'Go after it': GOP strategists say Republicans need to hit Biden on drug pricing POLITICO
- Biden Administration Unveils First Drugs for Medicare Price Negotiations The New York Times
- A major development in the fight against prescription drug costs CNN
Reading Insights
0
8
2 min
vs 3 min read
79%
491 → 103 words
Want the full story? Read the original article
Read on The Guardian US